Hospital Medicine

In the conclusion of this case discussion, Robert M. Centor, MD, discusses the origins of the patient's hyponatremia as well as the proper course of treatment.

In the conclusion of this case study, George Bakris, MD, discusses proper treatment of resistant hypertension and the importance of ruling out "pseudo-resistance."

Robert M. Centor, MD, introduces the case of a 60-year-old woman with known paranoid schizophrenia and major depressive disorder who presents to the ER after having multiple seizures.

George Bakris, MD, introduces the case of a 54-year-old man who presents to the emergency room and appears to have resistant hypertension.

In the first part of our article on chronic obstructive pulmonary disease, our panelists discuss challenges in diagnosing the condition and how to distinguish it from asthma.

In the second part of our article on chronic obstructive pulmonary disease, our panelists discuss the development and implentation of clinical practice guidelines for the condition.

In the third part of our article on chronic obstructive pulmonary disease, our panelists emphasize that it is never too late to treat COPD and share a laugh over the challenges of teaching patients how to use inhalers properly.

In the final part of our article on chronic obstructive pulmonary disease, our panelists discuss what hospitalists can do to diagnose the condition at the time of an exacerbation and how they can become better at acute management of the disease.

In this set of online exclusive excerpts from our expert panel discussion on chronic obstructive pulmonary disease, our panelists discuss non-pharmacologic methods of treating COPD, including pulmonary rehabilitation and smoking cessation.

A recent study concluded that patient care by hospitalists was associated with shorter stays and lower hospital charges, but those savings were offset by higher post-discharge Medicare costs. We spoke with the study's lead author, biostatistician Yong-Fang Kuo, PhD, of the University of Texas Medical Branch at Galveston.

Antimicrobial programs, which need to be closely connected to infection control programs and clinical microbiology labs, are playing an emerging role in slowing the spread of methicillin-resistant Staphylococcus aureus.

Concerns about methicillin-resistant Staphylococcus aureus (MRSA) infection skyrocketed in 2000, when its prevalence in the US dramatically increaseed. One key to fighting MRSA is preventing its transmission.

Methicillin-resistant Staphylococcus aureus (MRSA) infections are becoming more common in hospitals and health care facilities and have still higher incidence rates in nursing homes and long-term-care facilities. Listen here for valuable information on MRSA prevention and treatment.

Screening is thought by many to play a key role in reducing the incidence of methicillin-resistant Staphylococcus aureus infection, but some argue that it isn't always necessary.

Guidelines from organizations such as the Infectious Disease Society of North America play a key role in the treatment of methicillin-resistant Staphylococcus aureus and can help determine which therapies work best for which patients.

When treating methicillin-resistant Staphylococcus aureus infection, some clinicians have argued that newer, costlier drugs can save money if used from the beginning in place of older, cheaper alternatives.